MedImmune’s FluMist Approved For Children As Young As Age Two
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm will begin shipments immediately to make doses available for the 2007-2008 influenza season.
You may also be interested in...
MedImmune FluMist Manufacturing Violations Cited In FDA Warning Letter
FDA also issued a “complete response” letter for MedImmune’s sBLA for the vaccine in younger children as a result of the compliance issues.
AstraZeneca Accelerates Biologics Strategy With Acquisition Of MedImmune
Following the merger, valued at roughly $15.6 billion, 27 percent of AstraZeneca’s portfolio will be in biologics.
MedImmune’s Refrigerated FluMist To Be Priced At Slight Discount To Old Formulation
The firm will focus marketing efforts on pediatricians.